For research use only. Not for therapeutic Use.
ABC34 (CAT: R066448) is an inactive control compound for JJH260, primarily used in enzymatic and biochemical studies. It does not inhibit the fluorophosphonate reactivity or the hydrolysis of fatty acid esters of hydroxy fatty acids (FAHFA) mediated by AIG1. However, it exhibits inhibitory activity against ABHD6 and PPT122, enzymes involved in lipid metabolism and signaling pathways. Given its role in modulating lipid-related enzymatic activity, ABC34 is most relevant to Metabolic Disease Research, particularly in the study of lipid hydrolases and their implications in metabolic disorders, obesity, and inflammation. Its use as a control compound aids in distinguishing selective inhibitory effects in biochemical assays.
| Catalog Number | R066448 |
| CAS Number | 1831135-56-8 |
| Synonyms | [1,3-dioxo-7-[(4-phenoxyphenyl)methyl]-5,6,8,8a-tetrahydroimidazo[1,5-a]pyrazin-2-yl] 4-(4-methoxyphenyl)piperazine-1-carboxylate |
| Molecular Formula | C31H33N5O6 |
| Purity | ≥95% |
| IUPAC Name | [1,3-dioxo-7-[(4-phenoxyphenyl)methyl]-5,6,8,8a-tetrahydroimidazo[1,5-a]pyrazin-2-yl] 4-(4-methoxyphenyl)piperazine-1-carboxylate |
| InChI | InChI=1S/C31H33N5O6/c1-40-25-13-9-24(10-14-25)33-16-18-34(19-17-33)31(39)42-36-29(37)28-22-32(15-20-35(28)30(36)38)21-23-7-11-27(12-8-23)41-26-5-3-2-4-6-26/h2-14,28H,15-22H2,1H3 |
| InChIKey | JJXNIRULKJQOCI-UHFFFAOYSA-N |
| SMILES | COC1=CC=C(C=C1)N2CCN(CC2)C(=O)ON3C(=O)C4CN(CCN4C3=O)CC5=CC=C(C=C5)OC6=CC=CC=C6 |
